Stay updated on AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial
Sign up to get notified when there's something new on the AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial page.

Latest updates to the AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check28 days agoChange DetectedThe webpage has been updated to include detailed information about the AGI-134 study, including its design, dosing regimen, and safety assessments, while removing some previous descriptions and dates related to the study's results and protocols.SummaryDifference34%
- Check35 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check42 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check57 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check64 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.2%
Stay in the know with updates to AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial page.